What They’re Watching: Rep. Jennifer Dailey-Provost

Rep. Jennifer Dailey-Provost is a member of the House Health and Human Services Committee. She joins us in this edition of “What They’re Watching” to discuss Medicaid expansion and costs.

Get the latest state-specific policy intelligence for the health care sector delivered to your inbox.

I’m watching to see how the waiver application process for our Medicaid expansion bill is coming along — got a July 1st 2020 deadline before we either get waivers approved or we revert back to full Medicaid expansion that was passed in Proposition 3.

Nationally, I’m looking at the multi-state lawsuit…suing the federal government over the ACA. But, we’re also looking at this ever-omnipresent issue of the cost of health care that continues to balloon, that continues to blow up our national expenditures. By a long way, we spend the most on health care as a measure of GDP than any industrialized nation in the world, and we have worse health outcomes. We shouldn’t be spending more to have less good health than any of the rest of the industrialized world.

And so, we talked about that a lot. We talked about price transparency so that people, you know, if health care so expensive, understanding why the outrageous price of prescription drugs and things like insulin becoming extraordinary — you know, 5 to 10 times more expensive than it has been for years — that something has to change.

We’ve got some great movement here in the state of Utah: Intermountain Healthcare is creating its own company to create generic medications, to kind of put some market forces on some of these problems with drug costs in our nation.